• Ohio HB 376 (130th General Assembly) was recently signed into law and provision go into effect March 20, 2015. Health care providers should be aware that the law includes two provisions relating to controlled substances containing buprenorphine used for the purpose of treating drug dependence or addiction. Click this link for complete information:
  • Effective February 1, 2015, rule 4729-5-10 of the Ohio Administrative Code, which permits entities (known as Pick-up Stations) to receive patient-specific prescription medication on behalf of the end user/patient, will be amended. Click this link for complete
  • The FDA and CDC are continuing to investigate multiple instances of Wallcur’s simulated intravenous (IV) saline products being administered to patients. These products are not sterile and should not be injected in humans or animals. Click this link for complete information:
  • Finally, the Ohio State Board of Pharmacy has a number of new and amended rules that went into effect on January 20, 2015.  For more information on these rules, please visit: